Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-09-06 Purchase |
2023-09-06 4:39 pm |
ZEVRA THERAPEUTICS INC. | ZVRA | Anderson Thomas Director |
10,000 | $4.8764 | $48,764 | 10,000 (Direct) |
View |
2023-05-19 Purchase |
2023-06-30 4:14 pm |
ZEVRA THERAPEUTICS INC. | ZVRA | Schafer Joshua CCO & EVP, Bus. Development |
1,000 | $5.4157 | $5,416 | 3,000 (Direct) |
View |
2023-06-23 Purchase |
2023-06-26 4:19 pm |
ZEVRA THERAPEUTICS INC. | ZVRA | Watton Corey Michael Director |
275 | $5.9479 | $1,636 | 1,000 (Direct) |
View |
2023-06-09 Purchase |
2023-06-13 8:35 pm |
ZEVRA THERAPEUTICS INC. | ZVRA | Watton Corey Michael Director |
325 | $5.52 | $1,794 | 1,125 (Direct) |
View |
2023-05-30 Purchase |
2023-05-31 11:34 am |
ZEVRA THERAPEUTICS INC. | ZVRA | Watton Corey Michael Director |
400 | $5.1053 | $2,042 | 400 (Direct) |
View |
2023-05-18 Purchase |
2023-05-19 5:53 pm |
ZEVRA THERAPEUTICS INC. | ZVRA | Bode John B Director |
10,000 | $5.0418 | $50,418 | 10,000 (Direct) |
View |
2023-05-18 Purchase |
2023-05-18 4:56 pm |
ZEVRA THERAPEUTICS INC. | ZVRA | Clifton R. LaDuane CFO, Secretary & Treasurer |
2,740 | $4.9496 | $13,562 | 13,742 (Direct) |
View |
2023-03-17 Purchase |
2023-03-21 4:32 pm |
ZEVRA THERAPEUTICS INC. | ZVRA | SEYMOUR TAMARA A Director |
519 | $4.8215 | $2,502 | 719 (Direct) |
View |
2023-03-14 Purchase |
2023-03-15 8:14 pm |
ZEVRA THERAPEUTICS INC. | ZVRA | Schafer Joshua CCO & EVP, Bus. Development |
2,000 | $4.6089 | $9,218 | 2,000 (Direct) |
View |
2023-03-09 Purchase |
2023-03-13 07:59 am |
ZEVRA THERAPEUTICS INC. | ZVRA | Plooster Matthew R Director |
11,000 | $4.1953 | $46,148 | 20,101 (Indirect Direct) |
View |
2023-03-10 Purchase |
2023-03-13 07:57 am |
ZEVRA THERAPEUTICS INC. | ZVRA | Sangiovanni Timothy J. SVP, Corporate Controller |
1,200 | $4.1393 | $4,967 | 4,449 (Direct) |
View |
2023-03-10 Purchase |
2023-03-13 07:56 am |
ZEVRA THERAPEUTICS INC. | ZVRA | Clifton R. LaDuane CFO, Secretary & Treasurer |
1,725 | $4.15 | $7,159 | 11,002 (Direct) |
View |
2023-03-09 Purchase |
2023-03-13 07:54 am |
ZEVRA THERAPEUTICS INC. | ZVRA | Tierney David S Director |
5,000 | $4.1463 | $20,732 | 10,835 (Direct) |
View |
2023-03-09 Purchase |
2023-03-13 07:53 am |
ZEVRA THERAPEUTICS INC. | ZVRA | Pascoe Richard W Chief Executive Officer |
10,000 | $4.1978 | $41,978 | 29,973 (Direct) |
View |
2023-01-13 Purchase |
2023-01-13 5:28 pm |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO, Secretary & Treasurer |
635 | $5.8107 | $3,690 | 9,277 (Direct) |
View |
2023-01-13 Purchase |
2023-01-13 5:27 pm |
KEMPHARM INC | KMPH | Pascoe Richard W Chief Executive Officer |
9,500 | $5.4399 | $51,679 | 19,973 (Direct) |
View |
2022-09-30 Purchase |
2022-10-03 7:57 pm |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO, Secretary & Treasurer |
1,000 | $5.9812 | $5,981 | 8,109 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-08-07 Option Award |
2023-08-25 4:19 pm |
N/A 2033-08-06 |
ZEVRA THERAPEUTICS INC. | ZVRA | Anderson Thomas Director |
58,800 | $0 | 58,800 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 4:33 pm |
N/A 2033-05-30 |
ZEVRA THERAPEUTICS INC. | ZVRA | FAVORITO TAMARA A Director |
10,000 | $0 | 10,000 (Direct) |
View |
2023-05-03 Option Award |
2023-05-11 8:02 pm |
N/A 2033-05-02 |
ZEVRA THERAPEUTICS INC. | ZVRA | Calder Douglas W Director |
58,800 | $0 | 58,800 (Direct) |
View |
2023-05-03 Option Award |
2023-05-08 9:55 pm |
N/A 2033-05-02 |
ZEVRA THERAPEUTICS INC. | ZVRA | Watton Corey Michael Director |
58,800 | $0 | 58,800 (Direct) |
View |
2023-04-25 Option Award |
2023-05-08 9:54 pm |
N/A 2033-04-24 |
ZEVRA THERAPEUTICS INC. | ZVRA | Saluri Joseph Director |
39,200 | $0 | 39,200 (Direct) |
View |
2023-04-25 Option Award |
2023-05-08 9:53 pm |
N/A 2033-04-24 |
ZEVRA THERAPEUTICS INC. | ZVRA | Plooster Matthew R Director |
49,200 | $0 | 49,200 (Direct) |
View |
2023-04-25 Option Award |
2023-05-08 9:51 pm |
N/A 2033-04-24 |
ZEVRA THERAPEUTICS INC. | ZVRA | FAVORITO TAMARA A Director |
39,200 | $0 | 39,200 (Direct) |
View |
2023-04-25 Option Award |
2023-05-08 9:50 pm |
N/A 2033-04-24 |
ZEVRA THERAPEUTICS INC. | ZVRA | DIXON WENDY L Director |
58,800 | $0 | 58,800 (Direct) |
View |
2023-05-03 Option Award |
2023-05-08 9:44 pm |
N/A 2033-05-02 |
ZEVRA THERAPEUTICS INC. | ZVRA | Bode John B Director |
58,800 | $0 | 58,800 (Direct) |
View |
2023-01-09 Option Award |
2023-01-11 9:57 pm |
N/A 2033-01-08 |
KEMPHARM INC | KMPH | Clifton R. LaDuane CFO, Secretary & Treasurer |
459,726 | $0 | 459,726 (Direct) |
View |
2023-01-09 Option Award |
2023-01-11 9:52 pm |
N/A 2033-01-08 |
KEMPHARM INC | KMPH | Mickle Christal M M Chief Product Dev. Officer |
300,000 | $0 | 300,000 (Direct) |
View |
2023-01-09 Option Award |
2023-01-11 9:50 pm |
N/A 2033-01-08 |
KEMPHARM INC | KMPH | Guenther Sven Chief Scientific Officer |
306,000 | $0 | 306,000 (Direct) |
View |
2023-01-09 Option Award |
2023-01-11 9:49 pm |
N/A 2033-01-08 |
KEMPHARM INC | KMPH | Schafer Joshua CCO & EVP, Bus. Development |
300,000 | $0 | 300,000 (Direct) |
View |
2023-01-09 Option Award |
2023-01-11 9:46 pm |
N/A 2033-01-08 |
KEMPHARM INC | KMPH | Pascoe Richard W Chief Executive Officer |
700,000 | $0 | 700,000 (Direct) |
View |
2023-01-09 Option Award |
2023-01-11 9:45 pm |
N/A 2033-01-08 |
KEMPHARM INC | KMPH | Sangiovanni Timothy J. SVP, Corporate Controller |
136,986 | $0 | 136,986 (Direct) |
View |
Ownership |
2023-01-10 9:19 pm |
N/A N/A |
KEMPHARM INC | KMPH | Mickle Christal M M Chief Product Dev. Officer |
0 | $0 | 249,228 (Direct) |
View |
Ownership |
2022-11-30 4:40 pm |
N/A 2032-11-27 |
KEMPHARM INC | KMPH | Posner Christopher Director |
0 | $0 | 22,500 (Direct) |
View |